血小板减少性紫癜-话题@MedSci

#血小板减少性紫癜#

19篇内容 | 1173人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2065996, encodeId=5b242065996b0, content=<a href='/topic/show?id=9eac8901654' target=_blank style='color:#2F92EE;'>#血小板减少性紫癜#</a>, objectTitle=【要点解读】血栓性血小板减少性紫癜诊断与治疗中国指南（2022年版）, objectType=article, longId=733584, objectId=106ee3358464, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=106ee3358464, replyNumber=0, likeNumber=102, createdTime=2023-05-19, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=106ee3358464, moduleTitle=【要点解读】血栓性血小板减少性紫癜诊断与治疗中国指南（2022年版）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=106ee3358464)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2065994, encodeId=58012065994ea, content=<a href='/topic/show?id=9eac8901654' target=_blank style='color:#2F92EE;'>#血小板减少性紫癜#</a>, objectTitle=Ann Hematol：在卡帕珠单抗前时代获得性血栓性血小板减少性紫癜的死亡率, objectType=article, longId=293184, objectId=ac6f29318456, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ac6f29318456, replyNumber=0, likeNumber=66, createdTime=2022-12-02, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ac6f29318456, moduleTitle=Ann Hematol：在卡帕珠单抗前时代获得性血栓性血小板减少性紫癜的死亡率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ac6f29318456)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2065995, encodeId=295320659951f, content=<a href='/topic/show?id=9eac8901654' target=_blank style='color:#2F92EE;'>#血小板减少性紫癜#</a>, objectTitle=Ann Hematol：19 种药物疗法对特发性血小板减少性紫癜患者的疗效比较, objectType=article, longId=295695, objectId=6641295695e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6641295695e2, replyNumber=0, likeNumber=74, createdTime=2022-12-16, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6641295695e2, moduleTitle=Ann Hematol：19 种药物疗法对特发性血小板减少性紫癜患者的疗效比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6641295695e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2065993, encodeId=b2c2206599329, content=<a href='/topic/show?id=9eac8901654' target=_blank style='color:#2F92EE;'>#血小板减少性紫癜#</a>, objectTitle=Ann Rheum Dis：特发性血小板减少性紫癜患者出现系统性红斑狼疮的风险, objectType=article, longId=191502, objectId=e12c191502b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e12c191502b7, replyNumber=0, likeNumber=83, createdTime=2021-02-24, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e12c191502b7, moduleTitle=Ann Rheum Dis：特发性血小板减少性紫癜患者出现系统性红斑狼疮的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e12c191502b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2065992, encodeId=9842206599224, content=<a href='/topic/show?id=9eac8901654' target=_blank style='color:#2F92EE;'>#血小板减少性紫癜#</a>, objectTitle=NEJM：血栓性血小板减少性紫癜-病例报道, objectType=article, longId=164519, objectId=cb141645196d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb141645196d, replyNumber=0, likeNumber=0, createdTime=2020-03-20, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb141645196d, moduleTitle=NEJM：血栓性血小板减少性紫癜-病例报道, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb141645196d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2065991, encodeId=ed332065991ea, content=<a href='/topic/show?id=9eac8901654' target=_blank style='color:#2F92EE;'>#血小板减少性紫癜#</a>, objectTitle=Blood：先天性血栓性血小板减少性紫癜患者特征与治疗, objectType=article, longId=164242, objectId=cdbd16424296, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cdbd16424296, replyNumber=0, likeNumber=52, createdTime=2019-09-30, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cdbd16424296, moduleTitle=Blood：先天性血栓性血小板减少性紫癜患者特征与治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cdbd16424296)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2065989, encodeId=1fcf2065989d1, content=<a href='/topic/show?id=9eac8901654' target=_blank style='color:#2F92EE;'>#血小板减少性紫癜#</a>, objectTitle=NEJM：Caplacizumab治疗获得性血栓性血小板减少性紫癜, objectType=article, longId=157831, objectId=e6d915e83128, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e6d915e83128, replyNumber=0, likeNumber=86, createdTime=2019-12-09, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e6d915e83128, moduleTitle=NEJM：Caplacizumab治疗获得性血栓性血小板减少性紫癜, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e6d915e83128)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2065988, encodeId=7aa620659882f, content=<a href='/topic/show?id=9eac8901654' target=_blank style='color:#2F92EE;'>#血小板减少性紫癜#</a>, objectTitle=【盘点】血小板减少性紫癜近期重要研究进展汇总, objectType=article, longId=151539, objectId=7f6b151539f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7f6b151539f8, replyNumber=0, likeNumber=63, createdTime=2019-05-19, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7f6b151539f8, moduleTitle=【盘点】血小板减少性紫癜近期重要研究进展汇总, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7f6b151539f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2065990, encodeId=6c1c2065990db, content=<a href='/topic/show?id=9eac8901654' target=_blank style='color:#2F92EE;'>#血小板减少性紫癜#</a>, objectTitle=BMC Surgery：术前第1天血小板计数可以预测中国患有特发性血小板减少性紫癜的患者对腹腔镜脾切除术的长期反应, objectType=article, longId=162578, objectId=63f41625e806, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=63f41625e806, replyNumber=0, likeNumber=65, createdTime=2019-10-07, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=63f41625e806, moduleTitle=BMC Surgery：术前第1天血小板计数可以预测中国患有特发性血小板减少性紫癜的患者对腹腔镜脾切除术的长期反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=63f41625e806)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2065985, encodeId=07d7206598557, content=<a href='/topic/show?id=9eac8901654' target=_blank style='color:#2F92EE;'>#血小板减少性紫癜#</a>, objectTitle=FDA批准SYK抑制剂用于治疗慢性免疫性血小板减少性紫癜, objectType=article, longId=135793, objectId=34e3135e935e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=34e3135e935e, replyNumber=0, likeNumber=56, createdTime=2019-03-24, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=34e3135e935e, moduleTitle=FDA批准SYK抑制剂用于治疗慢性免疫性血小板减少性紫癜, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=34e3135e935e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2065986, encodeId=be6d2065986ed, content=<a href='/topic/show?id=9eac8901654' target=_blank style='color:#2F92EE;'>#血小板减少性紫癜#</a>, objectTitle=Blood：利妥昔单抗预处理可降低血栓形成性血小板减少性紫癜患者的长期复发率, objectType=article, longId=148679, objectId=fdc51486e958, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fdc51486e958, replyNumber=0, likeNumber=83, createdTime=2018-09-27, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fdc51486e958, moduleTitle=Blood：利妥昔单抗预处理可降低血栓形成性血小板减少性紫癜患者的长期复发率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fdc51486e958)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2065984, encodeId=8a16206598444, content=<a href='/topic/show?id=9eac8901654' target=_blank style='color:#2F92EE;'>#血小板减少性紫癜#</a>, objectTitle=Blood：脾切除仅能缓解特发性免疫性血小板减少性紫癜（ITP）的症状，并不能根治。, objectType=article, longId=125569, objectId=e81912556915, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e81912556915, replyNumber=0, likeNumber=75, createdTime=2018-11-25, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e81912556915, moduleTitle=Blood：脾切除仅能缓解特发性免疫性血小板减少性紫癜（ITP）的症状，并不能根治。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e81912556915)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2065987, encodeId=7dd1206598e3c, content=<a href='/topic/show?id=9eac8901654' target=_blank style='color:#2F92EE;'>#血小板减少性紫癜#</a>, objectTitle=Principia 制药宣布PRN1008获得FDA孤儿药认定用于治疗免疫性血小板减少性紫癜, objectType=article, longId=151535, objectId=817b1515353f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=817b1515353f, replyNumber=0, likeNumber=62, createdTime=2018-12-16, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=817b1515353f, moduleTitle=Principia 制药宣布PRN1008获得FDA孤儿药认定用于治疗免疫性血小板减少性紫癜, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=817b1515353f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2065982, encodeId=b799206598257, content=<a href='/topic/show?id=9eac8901654' target=_blank style='color:#2F92EE;'>#血小板减少性紫癜#</a>, objectTitle=Blood：阿伐他丁可增强糖皮质激素耐受性的免疫性血小板减少性紫癜患者的骨髓内皮细胞的功能。, objectType=article, longId=125208, objectId=c66f1252082a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c66f1252082a, replyNumber=0, likeNumber=80, createdTime=2018-10-14, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c66f1252082a, moduleTitle=Blood：阿伐他丁可增强糖皮质激素耐受性的免疫性血小板减少性紫癜患者的骨髓内皮细胞的功能。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c66f1252082a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2065981, encodeId=54252065981db, content=<a href='/topic/show?id=9eac8901654' target=_blank style='color:#2F92EE;'>#血小板减少性紫癜#</a>, objectTitle=Blood：血栓性血小板减少性紫癜的病理生理过程, objectType=article, longId=107582, objectId=9c5e10e58235, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c5e10e58235, replyNumber=0, likeNumber=87, createdTime=2017-12-15, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c5e10e58235, moduleTitle=Blood：血栓性血小板减少性紫癜的病理生理过程, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9c5e10e58235)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2065983, encodeId=985b2065983b9, content=<a href='/topic/show?id=9eac8901654' target=_blank style='color:#2F92EE;'>#血小板减少性紫癜#</a>, objectTitle=J Thromb Haemost：特发性血小板减少性紫癜与心血管疾病之间的相关性分析！, objectType=article, longId=125525, objectId=5dd11255255b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5dd11255255b, replyNumber=0, likeNumber=76, createdTime=2018-01-27, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5dd11255255b, moduleTitle=J Thromb Haemost：特发性血小板减少性紫癜与心血管疾病之间的相关性分析！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5dd11255255b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2065980, encodeId=6af820659809d, content=<a href='/topic/show?id=9eac8901654' target=_blank style='color:#2F92EE;'>#血小板减少性紫癜#</a>, objectTitle=Blood：血小板减少性紫癜史的妇女怀孕时可不治疗, objectType=article, longId=73167, objectId=06d5e3167d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=06d5e3167d1, replyNumber=0, likeNumber=73, createdTime=2017-01-08, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=06d5e3167d1, moduleTitle=Blood：血小板减少性紫癜史的妇女怀孕时可不治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=06d5e3167d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2065979, encodeId=c31c20659e999, content=<a href='/topic/show?id=9eac8901654' target=_blank style='color:#2F92EE;'>#血小板减少性紫癜#</a>, objectTitle=NEJM：Caplacizumab可缓解获得性血栓性血小板减少性紫癜，但增加出血危险, objectType=article, longId=63155, objectId=fb1d63155ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb1d63155ea, replyNumber=0, likeNumber=73, createdTime=2016-03-22, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb1d63155ea, moduleTitle=NEJM：Caplacizumab可缓解获得性血栓性血小板减少性紫癜，但增加出血危险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb1d63155ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2065978, encodeId=ff2e20659e847, content=<a href='/topic/show?id=9eac8901654' target=_blank style='color:#2F92EE;'>#血小板减少性紫癜#</a>, objectTitle=系统性红斑狼疮合并血栓性血小板减少性紫癜的临床特点, objectType=article, longId=18575, objectId=572e185e513, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=572e185e513, replyNumber=0, likeNumber=72, createdTime=2013-07-14, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=572e185e513, moduleTitle=系统性红斑狼疮合并血栓性血小板减少性紫癜的临床特点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=572e185e513)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

血小板减少性紫癜

2020-05-29

Tamikia (审核中...)

前往app查看评论内容

#血小板减少性紫癜#

【要点解读】血栓性血小板减少性紫癜诊断与治疗中国指南（2022年版）

2023-05-19

Tamikia (审核中...)

前往app查看评论内容

#血小板减少性紫癜#

Ann Hematol：在卡帕珠单抗前时代获得性血栓性血小板减少性紫癜的死亡率

2022-12-02

Tamikia (审核中...)

前往app查看评论内容

#血小板减少性紫癜#

Ann Hematol：19 种药物疗法对特发性血小板减少性紫癜患者的疗效比较

2022-12-16

Tamikia (审核中...)

前往app查看评论内容

#血小板减少性紫癜#

Ann Rheum Dis：特发性血小板减少性紫癜患者出现系统性红斑狼疮的风险

2021-02-24

Tamikia (审核中...)

前往app查看评论内容

#血小板减少性紫癜#

NEJM：血栓性血小板减少性紫癜-病例报道

2020-03-20

Tamikia (审核中...)

前往app查看评论内容

#血小板减少性紫癜#

Blood：先天性血栓性血小板减少性紫癜患者特征与治疗

2019-09-30

Tamikia (审核中...)

前往app查看评论内容

#血小板减少性紫癜#

NEJM：Caplacizumab治疗获得性血栓性血小板减少性紫癜

2019-12-09

Tamikia (审核中...)

前往app查看评论内容

#血小板减少性紫癜#

【盘点】血小板减少性紫癜近期重要研究进展汇总

2019-05-19

Tamikia (审核中...)

前往app查看评论内容

#血小板减少性紫癜#

BMC Surgery：术前第1天血小板计数可以预测中国患有特发性血小板减少性紫癜的患者对腹腔镜脾切除术的长期反应

2019-10-07

Tamikia (审核中...)

前往app查看评论内容

#血小板减少性紫癜#

FDA批准SYK抑制剂用于治疗慢性免疫性血小板减少性紫癜

2019-03-24

Tamikia (审核中...)

前往app查看评论内容

#血小板减少性紫癜#

Blood：利妥昔单抗预处理可降低血栓形成性血小板减少性紫癜患者的长期复发率

2018-09-27

Tamikia (审核中...)

前往app查看评论内容

#血小板减少性紫癜#

Blood：脾切除仅能缓解特发性免疫性血小板减少性紫癜（ITP）的症状，并不能根治。

2018-11-25

Tamikia (审核中...)

前往app查看评论内容

#血小板减少性紫癜#

Principia 制药宣布PRN1008获得FDA孤儿药认定用于治疗免疫性血小板减少性紫癜

2018-12-16

Tamikia (审核中...)

前往app查看评论内容

#血小板减少性紫癜#

Blood：阿伐他丁可增强糖皮质激素耐受性的免疫性血小板减少性紫癜患者的骨髓内皮细胞的功能。

2018-10-14

Tamikia (审核中...)

前往app查看评论内容

#血小板减少性紫癜#

Blood：血栓性血小板减少性紫癜的病理生理过程

2017-12-15

Tamikia (审核中...)

前往app查看评论内容

#血小板减少性紫癜#

J Thromb Haemost：特发性血小板减少性紫癜与心血管疾病之间的相关性分析！

2018-01-27

Tamikia (审核中...)

前往app查看评论内容

#血小板减少性紫癜#

Blood：血小板减少性紫癜史的妇女怀孕时可不治疗

2017-01-08

Tamikia (审核中...)

前往app查看评论内容

#血小板减少性紫癜#

NEJM：Caplacizumab可缓解获得性血栓性血小板减少性紫癜，但增加出血危险

2016-03-22

Tamikia (审核中...)

前往app查看评论内容

#血小板减少性紫癜#

系统性红斑狼疮合并血栓性血小板减少性紫癜的临床特点

2013-07-14

科室
- - 订阅+
  - 更多科室
工具
服务